Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

10 collaborators·24 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Palmetto Hematology Oncology, P.C.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Moderately Similar
13 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis
Similarity Score30%

William D Figg, Pharm.D.

National Cancer Institute (NCI)

Moderately Similar
11 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis
Similarity Score30%

E-mail: ClinicalTrials@ ImClone.com

Eli Lilly and Company

Moderately Similar
22 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis
Similarity Score30%

David S Schrump, M.D.

National Cancer Institute (NCI)

Moderately Similar
21 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis
Similarity Score30%

Antoni Ribas, MD

University of California, Los Angeles

Related
2 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Agop Y. Bedikian, MD

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Lee Cranmer, M.D.

University of Arizona

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

John Kirkwood, M.D.

University of Pittsburgh

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Andres Forero, M.D.

University of Alabama at Birmingham

Related
2 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Steven J. O'Day, M.D.

Cancer Institute Medical Group, Inc.

Related
1 trials

Shared therapeutic areas:

MelanomaNeoplasm Metastasis

Worked with same sponsors:

PDL BioPharma, Inc.
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00099970Phase 2PrincipalInvestigator

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

MelanomaMetastases
Completed

All 1 trials loaded